Amexdrug EBITDA vs. Price To Sales

AXRX Stock  USD 0  0.00  0.00%   
Considering the key profitability indicators obtained from Amexdrug's historical financial statements, Amexdrug may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in December. Profitability indicators assess Amexdrug's ability to earn profits and add value for shareholders.
For Amexdrug profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Amexdrug to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Amexdrug utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Amexdrug's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Amexdrug over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between Amexdrug's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amexdrug is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amexdrug's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Amexdrug Price To Sales vs. EBITDA Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Amexdrug's current stock value. Our valuation model uses many indicators to compare Amexdrug value to that of its competitors to determine the firm's financial worth.
Amexdrug is number one stock in ebitda category among its peers. It is rated fourth in price to sales category among its peers . The ratio of EBITDA to Price To Sales for Amexdrug is about  125,124 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Amexdrug by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Amexdrug's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Amexdrug Price To Sales vs. EBITDA

EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Amexdrug

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
380.83 K
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

Amexdrug

P/S

 = 

MV Per Share

Revenue Per Share

 = 
3.04 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.

Amexdrug Price To Sales Comparison

Amexdrug is currently under evaluation in price to sales category among its peers.

Amexdrug Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Amexdrug, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Amexdrug will eventually generate negative long term returns. The profitability progress is the general direction of Amexdrug's change in net profit over the period of time. It can combine multiple indicators of Amexdrug, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Amexdrug Corporation, a pharmaceutical and cosmeceutical company, through its subsidiaries, primarily distributes pharmaceutical products. Amexdrug Corporation was founded in 1963 and is based in Commerce, California. AMEXDRUG CORPORATION operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on PNK Exchange. It employs 9 people.

Amexdrug Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Amexdrug. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Amexdrug position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Amexdrug's important profitability drivers and their relationship over time.

Use Amexdrug in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amexdrug position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amexdrug will appreciate offsetting losses from the drop in the long position's value.

Amexdrug Pair Trading

Amexdrug Pair Trading Analysis

The ability to find closely correlated positions to Amexdrug could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amexdrug when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amexdrug - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amexdrug to buy it.
The correlation of Amexdrug is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amexdrug moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amexdrug moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amexdrug can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Amexdrug position

In addition to having Amexdrug in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Most Shorted Equities Thematic Idea Now

Most Shorted Equities
Most Shorted Equities Theme
Dynamically calculated list of top equities currently trending upward via a buy-out by investors. The Most Shorted Equities theme has 222 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Most Shorted Equities Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Amexdrug Pink Sheet Analysis

When running Amexdrug's price analysis, check to measure Amexdrug's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amexdrug is operating at the current time. Most of Amexdrug's value examination focuses on studying past and present price action to predict the probability of Amexdrug's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amexdrug's price. Additionally, you may evaluate how the addition of Amexdrug to your portfolios can decrease your overall portfolio volatility.